COVID-19 Researchers

Medicine & Life Sciences

1. Infections 100%
2. Coronavirus 87%
3. Alzheimer Disease 81%
4. HIV 72%
5. SARS Virus 65%
6. Therapeutics 64%
7. Genes 62%
8. T-Lymphocytes 62%
9. Lung 61%
10. Viruses 60%
11. Antibodies 57%
12. West Nile virus 53%
13. Pediatrics 51%
14. Severe Acute Respiratory Syndrome 49%
15. Sepsis 48%
16. Mortality 48%
17. Proteins 45%
18. Wounds and Injuries 45%
19. Virus Diseases 44%
20. Vaccines 43%
21. Child 42%
22. Heart Failure 42%
23. Lung Transplantation 42%
24. Filarial Elephantiasis 40%
25. Anti-Bacterial Agents 40%
26. Confidence Intervals 40%
27. Parkinson Disease 39%
28. Depression 39%
29. Population 39%
30. Immunity 38%
31. Brain 38%
32. Mutation 38%
33. Pandemics 38%
34. Dendritic Cells 37%
35. Randomized Controlled Trials 36%
36. Transplants 36%
37. West Nile Fever 35%
38. Antiviral Agents 34%
39. Macrophages 33%
40. Interferons 32%
41. Antigens 31%
42. Inflammation 31%
43. Biomarkers 30%
44. Cohort Studies 30%
45. Survival 30%
46. Hospital Emergency Service 30%
47. Odds Ratio 28%
48. Cytokines 28%
49. Monoclonal Antibodies 28%
50. Phenotype 27%
51. Amyloid 27%
52. Intensive Care Units 27%
53. Transplant Recipients 27%
54. Monocytes 27%
55. Allografts 26%
56. Messenger RNA 26%
57. Kidney 26%
58. B-Lymphocytes 26%
59. Genome 26%
60. Vaccination 25%
61. Elderly 25%
62. Delivery of Health Care 25%
63. Dengue Virus 25%
64. Epitopes 25%
65. Zika Virus 25%
66. Cerebrospinal Fluid 24%
67. Epidemiology 24%
68. Antimicrobial Stewardship 23%
69. Gene Expression 23%
70. Transcription Factors 23%
71. Vesicular Stomatitis 23%
72. Neoplasms 23%
73. Occupational Groups 23%
74. Communicable Diseases 22%
75. Cognitive Dysfunction 22%
76. Asthma 22%
77. Mass Drug Administration 22%
78. Physicians 22%
79. Systematic Reviews 21%
80. Flavivirus 21%
81. Clinical Trials 21%
82. Human Influenza 21%
83. RNA 21%
84. Incidence 21%
85. Critical Illness 21%
86. Safety 21%
87. Guidelines 21%
88. Health 21%
89. Apoptosis 20%
90. Epithelial Cells 20%
91. Hospitalization 20%
92. Comorbidity 20%
93. Neutralizing Antibodies 20%
94. Lymphocytes 20%
95. Tuberculosis 20%
96. Morbidity 20%
97. Brugia malayi 19%
98. Head and Neck Neoplasms 19%
99. Accidental Falls 19%
100. Hemorrhage 19%